Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: February 1, 2023

Breckenridge Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?

BRECKENRIDGE has forty-eight approved drugs.

There are five tentative approvals on BRECKENRIDGE drugs.

Summary for Breckenridge

US Patents:	0
Tradenames:	45
Ingredients:	45
NDAs:	48
Patent Litigation for Breckenridge:	See patent lawsuits for Breckenridge
PTAB Cases with Breckenridge as petitioner:	See PTAB cases with Breckenridge as petitioner

Drugs and US Patents for Breckenridge

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Breckenridge	MEGESTROL ACETATE	megestrol acetate	SUSPENSION;ORAL	204688-001	Dec 1, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Breckenridge	OMEPRAZOLE	omeprazole	CAPSULE, DELAYED REL PELLETS;ORAL	203481-001	Jul 3, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Breckenridge Pharm	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077714-001	Jun 4, 2010	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Breckenridge	ZOLEDRONIC ACID	zoledronic acid	INJECTABLE;INTRAVENOUS	091170-001	Mar 4, 2013	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Breckenridge	OMEPRAZOLE	omeprazole	CAPSULE, DELAYED REL PELLETS;ORAL	203481-002	Jul 3, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Breckenridge	POMALIDOMIDE	pomalidomide	CAPSULE;ORAL	210111-004	Oct 30, 2020		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Breckenridge	EXEMESTANE	exemestane	TABLET;ORAL	211031-001	Feb 21, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Mallinckrodt

Express Scripts

AstraZeneca

Colorcon

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.